APA (7th ed.) Citation

Vigneron, C., Le Stang, V., Decroocq, J., Péju, E., Burroni, B., Chapuis, N., . . . Pène, F. (2022). Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis. Acta Oncologica, 61(5), 608. https://doi.org/10.1080/0284186X.2022.2044517

Chicago Style (17th ed.) Citation

Vigneron, Clara, Valentine Le Stang, Justine Decroocq, Edwige Péju, Barbara Burroni, Nicolas Chapuis, Julien Charpentier, and Frédéric Pène. "Etoposide-containing Regimens for the Treatment of Critically Ill Patients with Hematological Malignancy-related Hemophagocytic Lymphohistiocytosis." Acta Oncologica 61, no. 5 (2022): 608. https://doi.org/10.1080/0284186X.2022.2044517.

MLA (9th ed.) Citation

Vigneron, Clara, et al. "Etoposide-containing Regimens for the Treatment of Critically Ill Patients with Hematological Malignancy-related Hemophagocytic Lymphohistiocytosis." Acta Oncologica, vol. 61, no. 5, 2022, p. 608, https://doi.org/10.1080/0284186X.2022.2044517.